AR and prostate carcinoma: Although previously reported as a tumor suppressor in glioblastoma [38], DHX15 has also been shown to promote prostate cancer by enhancing androgen receptor transcriptional activity [39], and its depletion has been linked to leukemia pathogenesis [40].